Potent antitumor effect of tumor microenvironment-targeted oncolytic adenovirus against desmoplastic pancreatic cancer

Organoid Models of Human and Mouse Ductal Pancreatic Cancer

(2015) Sylvia F. Boj et al.   CELL

A Novel CDC25B Promoter-Based Oncolytic Adenovirus Inhibited Growth of Orthotopic Human Pancreatic Tumors in Different Preclinical Models

(2015) H. L. Weber et al.   CLINICAL CANCER RESEARCH

Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids

(2015) Won Jai Lee et al.   EXPERIMENTAL DERMATOLOGY

Gene and cell therapy for pancreatic cancer

(2015) Hans Martin Singh et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model

(2015) Youjin Na et al.   JOURNAL OF CONTROLLED RELEASE

Preclinical models of pancreatic ductal adenocarcinoma

(2015) Chang-Il Hwang et al.   JOURNAL OF PATHOLOGY

Immunological data from cancer patients treated with Ad5/3 E2F Δ24 GMCSF suggests utility for tumor immunotherapy

(2015) Otto Hemminki et al.   Oncotarget

Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer

(2015) Simona Bramante et al.   OncoImmunology

European cancer mortality predictions for the year 2014

(2014) M. Malvezzi et al.   ANNALS OF ONCOLOGY

Hypoxia-inducible factor 1α expression and its clinical significance in pancreatic cancer: A meta-analysis

(2014) Long-Yun Ye et al.   PANCREATOLOGY

3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing

(2013) Paola Longati et al.   BMC CANCER

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

One mouse, one patient paradigm: New avatars of personalized cancer therapy

(2013) Prerna Malaney et al.   CANCER LETTERS

Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus

(2013) A. Kanerva et al.   CLINICAL CANCER RESEARCH

The Epidemiology of Pancreatitis and Pancreatic Cancer

(2013) Dhiraj Yadav et al.   GASTROENTEROLOGY

Enhanced antitumor immunotherapeutic effect of B-cell-based vaccine transduced with modified adenoviral vector containing type 35 fiber structures

(2013) E-K Kim et al.   GENE THERAPY

The immune network in pancreatic cancer development and progression

(2013) S M Wörmann et al.   ONCOGENE

The role of stroma in pancreatic cancer: diagnostic and therapeutic implications

(2012) Mert Erkan et al.   Nature Reviews Gastroenterology & Hepatology

A Novel sLRP6E1E2 Inhibits Canonical Wnt Signaling, Epithelial-to-Mesenchymal Transition, and Induces Mitochondria-Dependent Apoptosis in Lung Cancer

(2012) Jung-Sun Lee et al.   PLoS One

Developments in metastatic pancreatic cancer: Is gemcitabine still the standard?

(2012) Jie-Er Ying   WORLD JOURNAL OF GASTROENTEROLOGY

Clinical development directions in oncolytic viral therapy

(2011) R M Eager et al.   CANCER GENE THERAPY

A Hypoxia- and  -Fetoprotein-Dependent Oncolytic Adenovirus Exhibits Specific Killing of Hepatocellular Carcinomas

(2010) O.-J. Kwon et al.   CLINICAL CANCER RESEARCH

Oncolytic (replication-competent) adenoviruses as anticancer agents

(2010) Karoly Toth et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Stromal biology and therapy in pancreatic cancer

(2010) A. Neesse et al.   GUT

Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy

(2009) I-K Choi et al.   GENE THERAPY

Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs

(2008) Silvia Goldoni et al.   INTERNATIONAL JOURNAL OF CANCER